These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6966885)

  • 1. PGD3 is the mediator of the antiaggregatory effects of the trienoic endoperoxide PGH3.
    Whitaker MO; Needleman P; Wyche A; Fitzpatrick FA; Sprecher H
    Adv Prostaglandin Thromboxane Res; 1980; 6():301-3. PubMed ID: 6966885
    [No Abstract]   [Full Text] [Related]  

  • 2. Triene prostaglandins: prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances.
    Whitaker MO; Wyche A; Fitzpatrick F; Sprecher H; Needleman P
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5919-23. PubMed ID: 230492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 16-p-fluorophenoxy prostanoid with potent and long-lasting thromboxane-like actions [proceedings].
    Jones RL; Wilson NH
    Br J Pharmacol; 1978 Jun; 63(2):362P. PubMed ID: 667444
    [No Abstract]   [Full Text] [Related]  

  • 4. Manipulation of platelet aggregation by prostaglandins and their fatty acid precursors: pharmacological basis for a therapeutic approach.
    Needleman P; Whitaker MO; Wyche A; Watters K; Sprecher H; Raz A
    Prostaglandins; 1980 Jan; 19(1):165-81. PubMed ID: 6247744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prostaglandin I2 and analogs on platelet aggregation and smooth muscle contraction.
    Crane BH; Maish TL; Maddox YT; Corey EJ; Székely I; Ramwell PW
    J Pharmacol Exp Ther; 1978 Jul; 206(1):132-8. PubMed ID: 351171
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal vascular effects of endoperoxide analogs, prostaglandins, and arachidonic acid.
    Feigen LP; Chapnick BM; Flemming JE; Flemming JM; Kadowitz PJ
    Am J Physiol; 1977 Nov; 233(5):H573-9. PubMed ID: 920820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial agonism of prostaglandin H2 analogs and 11-deoxy-prostaglandin F2 alpha to thromboxane-sensitive preparations.
    Jones RL; Wilson NH
    Adv Prostaglandin Thromboxane Res; 1980; 6():467-75. PubMed ID: 7386280
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors affecting prostaglandin endoperoxide transformation: antibodies against PGH2.
    Fitzpatrick FA; Pike JE
    Prog Lipid Res; 1981; 20():179-82. PubMed ID: 7342082
    [No Abstract]   [Full Text] [Related]  

  • 9. Contractile effects of a PGH2 analog and PGD2 on intrapulmonary vessels.
    Gruetter CA; McNamara DB; Hyman AL; Kadowitz PJ
    Am J Physiol; 1978 Feb; 234(2):H139-45. PubMed ID: 623314
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues.
    Morinelli TA; Niewiarowski S; Kornecki E; Figures WR; Wachtfogel Y; Colman RW
    Blood; 1983 Jan; 61(1):41-9. PubMed ID: 6293626
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of lymphatic contractility by arachidonate metabolites.
    Johnston MG; Gordon JL
    Nature; 1981 Sep; 293(5830):294-7. PubMed ID: 7196995
    [No Abstract]   [Full Text] [Related]  

  • 12. Modulation of thrombus formation in vivo by prostaglandins [proceedings].
    Westwick J
    Br J Pharmacol; 1977 Sep; 61(1):138P-139P. PubMed ID: 912187
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of precursors, products, and product analogs of prostaglandin cyclooxygenase upon iris sphincter muscle.
    Crawford CG; van Alphen GW; Cook HW; Lands WE
    Life Sci; 1978 Sep; 23(12):1255-62. PubMed ID: 101727
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prostaglandins in hematology].
    Gavrilov OK; Kaveshnikov BF
    Sov Med; 1979 Nov; (11):67-75. PubMed ID: 118536
    [No Abstract]   [Full Text] [Related]  

  • 15. 9-deoxy-delta 9-prostaglandin D2, a prostaglandin D2 derivative with potent antineoplastic and weak smooth muscle-contracting activities.
    Fukushima M; Kato T; Ota K; Arai Y; Narumiya S; Hayaishi O
    Biochem Biophys Res Commun; 1982 Dec; 109(3):626-33. PubMed ID: 6961920
    [No Abstract]   [Full Text] [Related]  

  • 16. Preparation and biochemical properties of PGH3.
    Smith DR; Weatherly BC; Salmon JA; Ubatuba FB; Gryglewski RJ; Moncada S
    Prostaglandins; 1979 Sep; 18(3):423-38. PubMed ID: 531219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of xenobiotic cooxygenation coupled to prostaglandin H2 biosynthesis.
    Marnett LJ; Bienkowski MJ; Pagels WR; Reed GA
    Adv Prostaglandin Thromboxane Res; 1980; 6():149-51. PubMed ID: 6770592
    [No Abstract]   [Full Text] [Related]  

  • 18. 5'-Methylthioadenosine and 2',5'-dideoxyadenosine blockade of the inhibitory effects of adenosine on ADP-induced platelet aggregation by different mechanisms.
    Agarwal KC; Parks RE
    Biochem Pharmacol; 1980 Sep; 29(18):2529-32. PubMed ID: 6968562
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostacyclin stimulation of the activation of blood coagulation factor X by platelets.
    Dutta-Roy AK; Ray TK; Sinha AK
    Science; 1986 Jan; 231(4736):385-8. PubMed ID: 3001935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential actions of the prostaglandins on the pulmonary vascular bed.
    Kadowitz PJ; Spannhake EW; Levin JL; Hyman AL
    Adv Prostaglandin Thromboxane Res; 1980; 7():731-43. PubMed ID: 6989201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.